GR, the next best thing to a CURE is NED. This is one phrase all patients are longing to hear from their doctors. 113 is the only NSCLC drug on trial with the best BB penetration amongst competition.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.